SENEXON-S - 52959-675-02 - (DOCUSATE SODIUM -SENNOSIDES)

Alphabetical Index


Drug Information of SENEXON-S

Product NDC: 52959-675
Proprietary Name: SENEXON-S
Non Proprietary Name: DOCUSATE SODIUM -SENNOSIDES
Active Ingredient(s): 50; 8.6    mg/1; mg/1 & nbsp;   DOCUSATE SODIUM -SENNOSIDES
Administration Route(s): ORAL
Dosage Form(s): TABLET, COATED
Coding System: National Drug Codes(NDC)

Labeler Information of SENEXON-S

Product NDC: 52959-675
Labeler Name: H.J. Harkins Company, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part334
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20110316

Package Information of SENEXON-S

Package NDC: 52959-675-02
Package Description: 120 TABLET, COATED in 1 BOTTLE, PLASTIC (52959-675-02)

NDC Information of SENEXON-S

NDC Code 52959-675-02
Proprietary Name SENEXON-S
Package Description 120 TABLET, COATED in 1 BOTTLE, PLASTIC (52959-675-02)
Product NDC 52959-675
Product Type Name HUMAN OTC DRUG
Non Proprietary Name DOCUSATE SODIUM -SENNOSIDES
Dosage Form Name TABLET, COATED
Route Name ORAL
Start Marketing Date 20110316
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name H.J. Harkins Company, Inc.
Substance Name DOCUSATE SODIUM; SENNOSIDES A AND B
Strength Number 50; 8.6
Strength Unit mg/1; mg/1
Pharmaceutical Classes

Complete Information of SENEXON-S


General Information